Bioventus Inc.
BVSUS売上高
$568M
百万USD
営業利益
$54M
百万USD
純利益
$23M
百万USD
ROE
12.3%
最新FY
EPS
$0.33
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $82M | $25M | $-0.02 |
| FY2021 | Q2 | $110M | $-4M | $-0.10 |
| FY2021 | Q3 | $109M | $-1M | $-0.03 |
| FY2021 | FY | $431M | $-7M | $-0.15 |
| FY2022 | Q1 | $117M | $-11M | $-0.19 |
| FY2022 | Q2 | $140M | $-7M | $-0.11 |
| FY2022 | Q3 | $129M | $-108M | $-1.76 |
| FY2022 | FY | $512M | $-159M | $-2.59 |
| FY2023 | Q1 | $119M | $-139M | $-2.24 |
| FY2023 | Q2 | $137M | $-4M | $-0.06 |
| FY2023 | Q3 | $121M | $-7M | $-0.12 |
| FY2023 | FY | $512M | $-156M | $-2.49 |
| FY2024 | Q1 | $129M | $-5M | $-0.07 |
| FY2024 | Q2 | $151M | $-24M | $-0.37 |
| FY2024 | Q3 | $139M | $-5M | $-0.07 |
| FY2024 | FY | $573M | $-34M | $-0.52 |
| FY2025 | Q1 | $124M | $-3M | $-0.04 |
| FY2025 | Q2 | $148M | $7M | $0.11 |
| FY2025 | Q3 | $139M | $3M | $0.05 |
| FY2025 | FY | $568M | $23M | $0.33 |
| FY2026 | Q1 | $132M | $3M | $0.04 |
財務データ
| 指標 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| 売上高 | $431M | $512M | $512M | $573M | $568M |
| 営業利益 | $12M | $-251M | $-82M | $-12M | $54M |
| 純利益 | $-7M | $-159M | $-156M | $-34M | $23M |
| 総資産 | $1.2B | $1.4B | $811M | $728M | $684M |
| 純資産 | $534M | $340M | $221M | $186M | $228M |
| 自己資本 | $459M | $317M | $174M | $148M | $184M |
| 営業CF | $23M | $-14M | $15M | $39M | $75M |
| EPS | $-0.15 | $-2.59 | $-2.49 | $-0.52 | $0.33 |
| BPS | - | - | - | - | - |
| ROE | -1.4% | -50.1% | -90.0% | -22.7% | 12.3% |